This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Liminal BioSciences Management

Management criteria checks 2/4

Key information

Bruce Pritchard

Chief executive officer

CA$1.1m

Total compensation

CEO salary percentage54.8%
CEO tenure2.5yrs
CEO ownership0.04%
Management average tenure2.5yrs
Board average tenure4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Bruce Pritchard's remuneration changed compared to Liminal BioSciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2022CA$1mCA$618k

-CA$29m

Sep 30 2022n/an/a

-CA$31m

Jun 30 2022n/an/a

-CA$35m

Mar 31 2022n/an/a

-CA$42m

Dec 31 2021CA$1mCA$591k

-CA$44m

Sep 30 2021n/an/a

-CA$48m

Jun 30 2021n/an/a

-CA$49m

Mar 31 2021n/an/a

-CA$35m

Dec 31 2020CA$2mCA$556k

-CA$48m

Sep 30 2020n/an/a

-CA$75m

Jun 30 2020n/an/a

-CA$94m

Mar 31 2020n/an/a

-CA$232m

Dec 31 2019CA$5mCA$563k

-CA$150m

Sep 30 2019n/an/a

-CA$299m

Jun 30 2019n/an/a

-CA$298m

Mar 31 2019n/an/a

-CA$194m

Dec 31 2018CA$1mCA$575k

-CA$197m

Sep 30 2018n/an/a

-CA$131m

Jun 30 2018n/an/a

-CA$118m

Mar 31 2018n/an/a

-CA$115m

Dec 31 2017CA$3mCA$526k

-CA$112m

Sep 30 2017n/an/a

-CA$109m

Jun 30 2017n/an/a

-CA$119m

Mar 31 2017n/an/a

-CA$112m

Dec 31 2016CA$2mCA$531k

-CA$101m

Compensation vs Market: Bruce's total compensation ($USD832.66K) is above average for companies of similar size in the German market ($USD435.93K).

Compensation vs Earnings: Bruce's compensation has increased whilst the company is unprofitable.


CEO

Bruce Pritchard (48 yo)

2.5yrs

Tenure

CA$1,127,987

Compensation

Mr. Bruce Pritchard, BA, CA, FioD, served as Principal Financial Officer at Liminal BioSciences Inc. since September 3, 2021. Mr. Pritchard served as Chief Operating Officer of Small Molecule Therapeutics...


Leadership Team

NamePositionTenureCompensationOwnership
Bruce Pritchard
Chief Executive Officer2.5yrsCA$1.13m0.043%
CA$ 5.1k
Patrick Sartore
President2.5yrsCA$866.09k0.010%
CA$ 1.2k
Gary Bridger
Interim Chief Scientific Officer & Non-Independent Directorless than a yearCA$428.33kno data
Marie Iskra
Corporate Secretary & General Counsel3.7yrsCA$637.35kno data
N. Rusaw
Chief Financial Officer1.2yrsno datano data
Shrinal Inamdar
Manager of Investor Relations & Communicationsno datano datano data
Steven Burton
President of Prometic Bioseparations Ltdno dataCA$294.54kno data

2.5yrs

Average Tenure

48yo

Average Age

Experienced Management: PJ2's management team is considered experienced (2.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Gary Bridger
Interim Chief Scientific Officer & Non-Independent Director4yrsCA$428.33kno data
Aleksander Krstajic
Independent Chair of the Board2.7yrsCA$178.00kno data
Simon Best
Lead Independent Director9yrsCA$167.58k0.069%
CA$ 8.2k
Eugene Siklos
Non-Independent Director2.7yrsno datano data
Benny Soffer
Board Observer4.1yrsno datano data
Neil Klompas
Independent Director4yrsCA$132.23kno data
Timothy Wach
Independent Director4yrsCA$120.67k0.029%
CA$ 3.4k

4.0yrs

Average Tenure

58yo

Average Age

Experienced Board: PJ2's board of directors are considered experienced (4 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.